ALYGLO launch
With the burden of constant infections from primary immunodeficiency (PI), patients often disconnect from the people, places, and hobbies they care about most. For providers, prescribing immunoglobulin (IG) treatment offers a tried-and-true solution. The introduction of ALYGLO™ brings the proven protection patients need to get back to the things that make them shine. And with extra purification that removes >99% of coagulation factor XIa (FXIa), a plasma-based contaminant linked to intravenous immmunoglobulin (IVIG)-related thromboembolic events, ALYGLO provides a clean IVIG option to the PI community.
Less sick time. More you time. IT’S GLO TIME.
https://www.alyglo.com/